You're preparing a 510(k) submission and your predicate device was just recalled. Does your submission strategy need to change? Your design inputs and risk analysis now have a critical new data point
Here's what's happening right now: 35 new FDA enforcement actions were issued today. While the specific device categories aren't detailed in today's signal, this volume indicates active regulatory scrutiny across the medical device landscape.
For design engineers, this means your predicate device selection process just got more complex. A recall on your chosen predicate directly impacts your 510(k) substantial equivalence argument and requires immediate updates to your design history file under 21 CFR 820.30. More importantly, it provides crucial post-market surveillance data that should feed back into your risk management process per ISO 14971—specifically, your risk analysis inputs and hazard identification.
We analyzed this across 548,000+ regulatory records and found that predicate device issues often reveal systemic design flaws that cascade through multiple submissions. When a predicate is recalled, it typically indicates underlying design control failures that subsequent devices may inherit if not properly addressed in new design inputs.
See how your specific product codes compare and track predicate device performance at truemeddevice.com
Related Regulatory Signals
Endo-Model Replacement Plateau; Item Number: 15-0027/11;
Raz-AT (Attendant Tilt) Mobile Shower Commode Chair, Catalog Number Z300 UDI-DI code: (01)00628758003007 Raz-ART (Attendant Rotational Tilt) Mobile Shower Commode Chair, Catalog Number Z333 UDI-DI code: (01)00628758003335 Raz-AT600 (Bariatric Tilt) Mobile Shower Commode Chair, Catalog Number Z360 UDI-DI code: (01)00628758003601 Raz-SP (Self Propel) Mobile Shower Commode Chair, Catalog Number Z200 UDI-DI code: (01)00628758001003 Raz-AP (Attendant Propel) Mobile Shower Commode Chair, Catalog Number Z100 UDI-DI code: (01)00628758001003 The Raz Mobile Shower Commode Chair is intended to be used by people with mobility impairments, who may have difficulty in standing or keeping their balance while completing activities such as showering, toileting, or personal hygiene.
GEM Premier 5000; Part No. 00055415008.
See how these signals relate to your device
Start a free pilot to match signals to your product portfolio automatically.
Start PilotRelated Articles
Management review is next week. ISO 13485 5.6 requires external signal data as input. Your team hasn't gathered it yet, and you're staring at a blank slide for the board report on risk exposure and co
Here's what's happening right now: There were 10,384 new regulatory signals today, including 10,360 FDA Adverse Event Reports (MAUDE/MDRs) and 22 Health Canada mdl entries. Notably, Health Canada issued 2 new recalls: Auro-Canagliflozin for incorrect DIN labeling and LUXA-D for a foreign product in a capsule, both flagged for product safety. For your management review under QMSR and 21 CFR 820, this data isn't just noise—it's critical for quantifying risk exposure and benchmarking against compe
April 4, 2026
social_linkedinComplaint trends are rising for one product family but you can't tell if it's an industry-wide issue or yours alone. You're reviewing your CAPA dashboard, trying to prioritize investigations against l
Here's what's happening right now: 10,384 new regulatory signals hit the system today. That includes 10,360 new FDA adverse event reports (MAUDE/MDRs) and 2 new Health Canada recalls. One recall involves incorrect DIN labeling on a blister card (Auro-Canagliflozin), and another involves a foreign product in a capsule batch (LUXA-D). For your CAPA prioritization and complaint handling, notice the pattern in the MDRs: multiple reports for infusion set tubing detachment events and software/app mal
April 4, 2026
social_linkedinA competitor's device just got recalled. Your auditor will ask: 'How did you evaluate whether this affects your products?' You're reviewing the alert, knowing it could trigger a supplier audit or requ
Here's what's happening right now: 2 new Health Canada recalls were issued this week, both for product safety issues. Auro-Canagliflozin has affected lots with incorrect DIN labeling on blister cards, and LUXA-D has a capsule containing a foreign product in the batch. This adds to 10,360 new FDA Adverse Event Reports (MAUDE/MDRs) and 22 new Health Canada mdl signals today, totaling 10,384 new regulatory signals. For RA Managers focused on audit preparedness and post-market surveillance, these s
April 4, 2026